Related Experiment Videos
Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro
The Journal of Infectious Diseases
|October 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more.
medRxiv : the preprint server for health sciences·2023
Costs and management of patients with hemophilia A in France: the Hemraude study.
The European journal of health economics : HEPAC : health economics in prevention and care·2021
[Toxoplasmosis in pregnancy: Practical Management].
Gynecologie, obstetrique, fertilite & senologie·2021
HPV antibody concentrations among male and female adolescents after single-dose 9-valent HPV vaccination.
The Journal of infectious diseases·2026
Impact of dose on norovirus antibody kinetics following infection or vaccination.
The Journal of infectious diseases·2026
Systems analysis of immunity to pneumococcal vaccination in preterm and full term infants.
The Journal of infectious diseases·2026
Meropenem-Colistin Combination Mitigates Porin-Associated Carbapenem Resistance Development in Ertapenem-Mono-Resistant Enterobacterales.
The Journal of infectious diseases·2026
Temporal Changes in the Genetic Diversity and Relatedness of Plasmodium vivax Clinical Infections in Eastern Cambodia.
The Journal of infectious diseases·2026
A novel decentralized rapid test for detection of HCV antigens using smart polymer technology: a prospective multinational study.
The Journal of infectious diseases·2026
RNA virome comparison between sylvatic and urban-interface mosquitoes from Southeastern Brazil.
Frontiers in cellular and infection microbiology·2026
Mpox in the Republic of Korea from 2022 to June 2026: Epidemiological Trends and the First Clade Ib Case.
Public health weekly report·2026
Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes.
Frontiers in cardiovascular medicine·2026
Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.
British journal of clinical pharmacology·2026
MicroRNA-122 as a regulator and biomarker of liver disease.
Journal of molecular medicine (Berlin, Germany)·2026